comparemela.com

Latest Breaking News On - Processa pharmaceuticals inc - Page 8 : comparemela.com

Nasdaq Down Over 50 Points; Colgate-Palmolive Posts Upbeat Results - Colgate-Palmolive (NYSE:CL), AppFolio (NASDAQ:APPF)

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling over 50 points on Friday The Dow traded up 0.05% to 38,069.66 while the NASDAQ fell 0.4% to 15,447.78. The S&P 500 also fell, dropping, 0.15% to 4,886.79.

Shanghai
China
Germany
France
Italy
Spain
Japan
London
City-of
United-kingdom
German
French

Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering

HANOVER, Md., Jan. 26, 2024 Processa Pharmaceuticals, Inc. , a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy.

New-york
United-states
Patrick-lin
Processa-ngcs
Bret-shapiro
Hc-wainwright-co
Nasdaq
Company-contact
Exchange-commission
Processa-pharmaceuticals-inc
Processa-pharmaceuticals
Regulatory-science-approach

What's Going With Processa Pharmaceuticals Stock Today? - Processa Pharma (NASDAQ:PCSA)

Processa Pharmaceuticals stock surge - 148.8% gain to $5.10 post Next Generation Capecitabine (NGC-Cap) Phase 1b success.

Processa-pharmaceuticals
Processa-pharmaceuticals-inc
Next-generation-capecitabine
Cap-phase

Why Intel Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session - AppFolio (NASDAQ:APPF), Aclarion (NASDAQ:ACON)

Shares of Intel Corporation (NASDAQ: INTC) fell sharply during Friday’s session. Intel reported upbeat results for its fourth quarter, but issued a weak forecast for the first quarter.

United-states
American
Olin-corporation
Mobilicom-limited
Steven-seedhouse
Raymond-james
Repligen-corporation
Sagimet-biosciences
Spirit-airlines-inc
Processa-pharmaceuticals-inc
Intelligent-bio-solutions-inc
Jaguar-health-inc

Processa Pharmaceuticals (PCSA) Announces Successful Completion of Phase 1b Safety Evaluation of NGC-Cap in Patients with Advanced Cancer

Processa Pharmaceuticals (PCSA) Announces Successful Completion of Phase 1b Safety Evaluation of NGC-Cap in Patients with Advanced Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

David-young
Processa-pharmaceuticals-inc
Young
Nasdaq
Processa-pharmaceuticals
Next-generation-capecitabine
Cap-phase
Capecitabine-administered
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.